ephrin-a5 and Acute Lung Injury

ephrin-a5 has been researched along with Acute Lung Injury in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Li, T; Shan, L; Wang, Y; Wei, Y; Xu, L; Yu, P; Zhang, C; Zhong, H	1

Other Studies

1 other study(ies) available for ephrin-a5 and Acute Lung Injury

Article	Year
Andrographolide Derivative AL-1 Ameliorates LPS-induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome and Lung Permeability. Current pharmaceutical design, 2022, Volume: 28, Issue:30 Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Caspase 1; Claudin-1; Cytokines; Diterpenes; Ephrin-A5; Inflammasomes; Isoflurane; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Occludin; Permeability; Vascular Cell Adhesion Molecule-1	2022

Article

Year

Andrographolide Derivative AL-1 Ameliorates LPS-induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome and Lung Permeability.

Current pharmaceutical design, 2022, Volume: 28, Issue:30

Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Caspase 1; Claudin-1; Cytokines; Diterpenes; Ephrin-A5; Inflammasomes; Isoflurane; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Occludin; Permeability; Vascular Cell Adhesion Molecule-1

2022